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Liver transplantation has been a successful therapy for liver failure. However, a signiﬁcant number of recipients suﬀer from graft
dysfunction. Considerably, ischemia and reperfusion (I/R) injury is the most important factor leading to organ dysfunction,
although the pathogenesis has not been fully described. I/R injury have several established features that are accompanied by and/or
linked to bile duct loss or ductopenia, cholestasis, and biliary ductular proliferations in the posttransplant liver biopsy. However,
biliary marker levels increase usually only 5–7 days after transplantation. Intermediate ﬁlaments are one of the three cytoskeletal
proteins that have a major role in liver protection and maintaining both cellular structure and integrity of eukaryotic cells. We
reviewedthecaninelivertransplantationmodelasI/Rinjurymodeltodelineatetheintermediateﬁlamentsofthecytoskeletonthat
are probably the determinants in changing the phenotype of hepatocytes to cholangiocytes. Remarkably, this interesting feature
seems to occur earlier than frank cholestasis. We speculate that I/R liver injury through a phenotypical switch of the hepatocytes
may contribute to the poor outcome of the liver graft.
1.Introduction
Liver transplantation is an established therapy for both acute
and chronic liver failure. However, graft dysfunction remains
ap r o b l e ma ﬀecting up to one-third of the recipients, despite
reports of good to excellent long-term outcome. The organ
dysfunction is considered multifactorial, but ischemia and
reperfusion (I/R) injury is probably the most important con-
tributing factor, although the detailed steps of pathogenesis
are controversially debated. I/R injury is a major cause of
liver graft dysfunction resulting in adenosine triphosphate
(ATP) decrease, evidence of intracellular acidosis, and cell
swelling of the hepatocytes. This aspect is also accompanied
by or linked to bile duct loss or ductopenia, cholestasis,
and biliary ductular proliferations in the posttransplant
liver biopsy. However, biliary marker levels increase usually
only 5–7 days after transplantation stimulating several ﬁelds
of research in the last couple of decades. Cholestasis is
associated with high morbidity and mortality in patients
undergoing liver transplantation, and the steps reaching this
state are not completely understood. We reviewed the canine
liver transplantation model as I/R injury model to delineate
in detail the intermediate ﬁlaments of the cytoskeleton that
are probably the determinants in changing the phenotype
of hepatocytes to cholangiocytes, which seems to be a post-
transplant event occurring in the liver at an earlier stage
than frank cholestasis. Here, we speculate that I/R liver
injury through a phenotypical switch of the liver cells may
contribute to the poor outcome of the liver graft.
2. LiverTransplantation
Liver transplantation is widely known as the most eﬀective
therapy for both acute and chronic liver failure [1]. In
1963, Thomas Starzl, an American surgeon, Northwestern
UniversityMedicalSchoolgraduatewithdegreesinanatomy,
neurophysiology, and medicine, was the ﬁrst to perform the2 Journal of Biomedicine and Biotechnology
liver transplantation on a child suﬀering from biliary atresia
[2]. Despite the signiﬁcant success of liver transplantation,
infection, poor graft function, and rejection are major prob-
lems that may still contribute to death of the transplanted
patientortodeteriorationofthegraft.Reperfusionfollowing
long ischemia of liver during liver transplantation causes
severeinjury,whichisnowuniversallyindicatedasI/Rinjury
[1].I/Rinjuryofliverisamajorcauseofmorbidityandmor-
talityinpatientsundergoinglivertransplantation[3].Several
mechanisms and distinct pathways may involve I/R leading
to both initial poor functionand primary nonfunction of the
liverallograft[4].Threecytoskeletalproteinsformanetwork
that provide the cellular structure and fundamental integrity
of the eukaryotic cells: microﬁlaments, microtubules, and
intermediate ﬁlaments. The intermediate ﬁlament proteins
haveanimportantroleinliverprotectionagainstmechanical
and nonmechanical injury, which have been demonstrated
in animal models. Overexpression of proteins and mutations
of the corresponding keratin genes have been reported to
contribute to several human oncological and nononcological
diseases [5].
3. Cytoskeleton andKeratinsAreInvolvedin
the Development of the Intrahepatic Biliary
System(K19 andK7)
Eukaryotic cells have a unique cytoplasmic structure labeled
as cytoskeleton, which consists of three distinct kinds
of cytoskeletal ﬁlaments, including microﬁlaments, micro-
tubules, and intermediate ﬁlaments. Besides giving the
rigidity of the cell and maintaining cell shape and borders or
cell “scaﬀolding,” cytoskeleton plays important and probably
crucial roles in intracellular transport, cell division, gene
regulation, and signal transduction of the genetic infor-
mation [6, 7]. Actin, which is widely accepted to be a
highly conserved structure among diﬀerent species, is the
major protein that constitutes the microﬁlaments. There
are three known classes of human actin gene that have
been identiﬁed as β-, α-, and γ-actin. Cell-cell interaction,
signaltransduction,cellshapemaintenance,andcellmotility
are the central functions of actin [7]. Microtubules, which
have a diameter of around 23nm, are protoﬁlaments that
are important for the intracellular transport, movement of
cilia and ﬂagella, mitotic spindle, and cell wall synthesis.
Tubulins are the major component of microtubules. Both
microﬁlaments and microtubules have several groups of
binding proteins that modulate their stability and biological
functions, such as signal transduction [7]. Intermediate
ﬁlaments with around 10nm of diameter are more stable
than actin ﬁlaments and function in the maintenance of
cell shape by carrying tension. Intermediate ﬁlaments, which
include, for example, vimentin, glial ﬁbrillary acidic protein,
neuroﬁlament proteins, keratins, and nuclear lamins, orga-
nize the internal 3D cell structure anchoring cyto-organelles
and serving as structural scaﬀolds of the nucleus and cyto-
plasm. Cytokeratins (Ks) are the main protein family that
constitutes the intermediate ﬁlaments with more than ﬁfty
members that have been identiﬁed [8]. Polypeptides of the
Ks are variants and have been divided into type I and type II,
or acidic and basic, respectively [9]. Studies have shown that
each epithelial cell has a distinct content of cytokeratins (i.e.,
expression of keratins is described as tissue-speciﬁc manner)
playing a major role in the tissue identiﬁcation of metastasis
of unknown primary carcinomas [10]. Ks usually present
i nc e l l sa sh e t e r o p o l y m e r sp a i r sc o m p o s e do ft y p eI( K 9 –
K20) and type II (K1–K8). Similar to microﬁlaments and
microtubules, keratins have numbers of their preferential
binding proteins. K8 (MW 52KD) and K18 (MW 45KD)
are considered as the only Ks that are normally expressed
in human hepatocytes [10]. Moreover, both K8 and K18
have been found to be expressed in early development stage
of mouse embryos [11]. Immunohistochemical studies have
revealed that cholangiocytes (bile duct cells) express K7 (54
KD) and K19 (40 KD) in addition to K8 and K18 [12],
and those Ks have been used as valid markers for both
studies on development of the intrahepatic biliary system
and for assessment of bile duct damage [9]. It has also
been well established that cholangiocytes are derived from
hepatoblasts found around portal vein [13]. These cells show
a particularly intense expression of K8 and K18. As indicated
above, K7 and K19 have been linked to development of the
intrahepatic bile duct system in both humans and animal
models. The expression of K19 is useful to identify primitive
biliary cells, while the expression of K7 appears after 20
weeks of gestation in humans [13]. Both K7 and K19 are
consistentlyexpressedinthedevelopmentoftheintrahepatic
bile duct with elevated levels until one month of postnatal
age.Thus,inordertophenotypicallyswitchhepatoblastsinto
cholangiocytes,thesecellsshouldﬁrstlyexpressK19followed
by expression of K7 [13]. However, it has been shown
that hepatocytes might express K7 in response to diﬀerent
conditions, such as ductopenia and cholestasis [14], and,
interestingly,ithasbeenfoundthathepatocellularcarcinoma
cellsexpressingK19aresigniﬁcantlyassociatedwithreoccur-
rence of neoplasm after transplantation [15]. A recent study
has demonstrated that hepatocytes are frequently expressing
K7 in case of chronic liver allograft rejection [14]. Sergi et al.
have demonstrated that hepatocytes intensively expressed K7
and K19 early following cold ischemia in a canine isolated
perfused liver transplantation model [16]. Furthermore,
they demonstrated that bile duct cytokeratins are very
useful markers to diagnose an early sign of cholestasis. It
has become clear that cholestasis is signiﬁcantly associated
with high morbidity and mortality in patients undergoing
liver transplantation. Therefore, investigations that lead to
discover the mechanisms of the cholestasis are dramatically
required.
4. Ischemia/Reperfusion (I/R) Injury
I/R injury is a phenomenon that occurs when blood ﬂow
a n do x y g e nd e l i v e r yr e t u r nt or e p e r f u s e dt i s s u e[ 17]. It
is considered one of the major causes of morbidity and
mortality among patients undergoing liver transplantation
[3]. I/R injury has been demonstrated in several diseases
suchascerebrovasculardiseases,peripheralvasculardiseases,
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[18]. It involves several mechanisms, which lead to organ
failure, circulatory dysfunction, and, ﬁnally, death of the
transplanted patient [1]. Cellular mechanisms of I/R injury
include a few essential cell cascades that suggest the role of
activation of endothelial cells, Kupﬀer cells, reactive oxygen
species (ROS), and polymorphonuclear leukocytes (PMN)
or neutrophils in the pathogenesis of I/R injury [19]. There
may also be mechanisms involving T lymphocytes that seem
to have a key role in short- and long-term damage during
I/R injury. T lymphocytes act as mediator in the subacute
inﬂammatory phase of neutrophilic recruitment following
I/R injury [20]. Another important constituent of tissue
injury following I/R injury that needs to be emphasized
is the production of oxygen free radicals (OFRs). These
OFRs can arise from diﬀerent sources, such as Kupﬀer
cells, PMN [1], and xanthine oxidase (XO) that is the
most signiﬁcant source [21]. Several etiological factors
are involved in I/R injury, including ATP reduction [16],
activation of proteases, and alteration in the intracellular
concentration of cytokines and chemokines [22], and cell
swelling [16]. Investigations of posttransplantation surgery
have indicated that reperfusion plays an essential role in
primary graft nonfunction, which is one of the most serious
complications of liver transplantation [23]. The incidence of
primary graft dysfunction is up to 20% [16]. I/R injury also
causes early organ failure up to 10% as well as increases the
acuteandchronicrejection[1].Severalstudiesdemonstrated
that during I/R injury, morphological changes of liver tissues
occur, and these changes can have a prognostic signiﬁcance.
5. Intermediate Filaments of Cytoskeleton
The intermediate ﬁlament (IF) cytoskeletal protein is one of
the three major cytoskeletal proteins whose result is impor-
tant in maintaining both cellular structure and integrity
of eukaryotic cells. The other two ﬁlament proteins are
microﬁlaments (MF) and microtubules (MT) [5]. Beside
their cellular functions like cell motility, division, and
stress responses, they also have an essential role in human
diseases due to mutations in ﬁlament proteins. For example,
mutation in actin microﬁlaments will cause cardiac and
noncardiacmyopathies[5].IFproteinsconsistofﬁvetypesof
keratins according to structure of genome and composition
of amino acid, IF proteins types I–IV are cytoplasmic,
and type V IF contain nuclear lamins [7]. The keratins
are obligating noncovalently heteropolymers because they
consist of one of each type I and type II keratins as pairs [9].
Type I or “acidic” and type II or “neutral to basic” keratins
are the largest group of IF proteins [7] classiﬁed as type
I (K9–K20) and type II (K1–K8) [24]. Another type of IF
proteins is type III IF that includes vimentin, peripherin,
glial ﬁbrillary acidic protein, and desmin of mesenchymal
cells, peripheral neurons, glia cells and astrocytes, and
muscle cells, respectively [7]. Type IV IF proteins include
neuroﬁlament proteins (NF-L, NF-M, and NF-H), synemin,
nestin, syncoilin, and α-internexin; lamins A–C for type
V IF proteins [24]. They are the major IF proteins in the
liver [5]. As indicated above, the adult hepatocytes express
K8 and K18 only compared to other epithelial cells that
e x p r e s s2o rm o r et y p eIo rt y p eI Ik e r a t i n s[ 9]s u c ha s
bile duct, which expresses additional keratins K7 and K19
[8]. Furthermore, alteration of the cytoskeletal proteins leads
to several diseases and disorders. The ﬁrst disease to be
discovered related to keratin mutation was epidermolysis
bullosa simplex (EBS) with mutations in K5 and K14.
White sponge nevus syndrome is another disease caused by
mutations in K4 and K13. It aﬀects noncornifying stratiﬁed
squamous epithelia in mouth, esophagus, and anogenital
mucosa [25]. Additionally, mutations in K8 and/or K18
lead to acute or chronic liver diseases [26]. Normally in
hepatocytes, the microﬁlaments are distributed in plasma
membrane and region of the bile canaliculus. Further
studies indicated that reperfusion alone causes alteration
of theses microﬁlaments (F-actin) leading to contraction
of canaliculi, relocalization of enzymes and transporters
of canaliculi, and increasing permeability of cellular tight
junction [16]. Cholestatic liver disease occurs when there is
a decrease in bile ﬂow, which is an abnormal physiologic
state, and retention of toxic bile acids [27]. All three ﬁlament
cytoskeletal proteins are remarkably altered in cholestatic
liver disease. Clear cytoplasmic hepatocytes (cholate stasis)
presented in cirrhotic nodules and showed a decrease in
keratin IF network in the cytoplasm [28]. Studies on mice
reported that keratin was overexpressed in epithelia of bile
duct due to ligation of bile duct and in hepatocytes. In
cholestatic liver disease, bile duct epithelial-type keratin (K7
and K19) was expressed in hepatocytes, too. Intermediate
hepatocytes express K7, while reactive bile ductules express
K7 and K19 [28]. In post-transplant period, morphological
changes in liver tissue have also been demonstrated. Keratins
of biliary type were detected in the hepatocytes in the early
period of I/R injury. Moreover, bile canaliculus progressively
dilate after ischemia, and a change of the microvillous
integrity is demonstrable [16].
6.CanineLiverTransplantationModel
The liver is one of the organs with an incredible capacity
for in vivo tissue engineering which allow restoration of
the liver architecture and reestablishment of certain vital
functions. The study of liver regeneration in humans arise
ethical issues, and it is diﬃcult to carry out because of a
plethora of heterogeneous liver lesions. Accordingly, using
experimental animal models is more useful and helpful for
studying liver regeneration [29]. In vitro studies need to
be followed by in vivo ones to simulate the interaction
between liver cell populations. In our opinion, the use of
largeanimalssuchasdog,pig,orsheepismoreadvantageous
than small animals like rat or mouse; large animals are
similar to human beings in their physiology and anatomy,
and techniques of microsurgery are not necessary to carry
out determinate experiments [29]. Only few studies have
been carried out on I/R animal models in liver [21].
The canine liver model following I/R injury has been
used as a liver transplantation model to study excretion
of bile and intrahepatic intermediate ﬁlaments expression
involved inmorphological changesofthebiliarysystem[16].
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perfused liver model, there was the ﬁrst clear-cut evidence
of cholestatic changes starting early following cold ischemia
despite prompt recovery of the bile ﬂow. According to some
other authors, the use of the canine liver transplantation
model seems to allow a better vascular perfusion under
ex vivo conditions in contrast to the rat model [5]. Sergi
et al.’s study revealed an ischemia-dependent impairment
of an experimental biliary dye excretion during early stage
of reperfusion and a progressive cytokeratin expression of
biliary type in the hepatocytes despite a prompt recovery
of the bile ﬂow after I/R. The recovery of the bile output
after I/R represents a key event in LT. The nonstimulated
bile ﬂow rate was unaﬀected by cold ischemia up to 10h in
our canine isolated perfused liver model, but the decrease of
the biliary dye excretion during early stage of reperfusion
correlated with the peak output rate of the dye across the
canalicular membrane. The transhepatic transit time was
prolonged with increasing ischemia time. Remarkably, the
dye uptake at the sinusoidal membrane was not aﬀected
by cold ischemia, leading to a possible accumulation of
toxic compounds in the hepatocytes. Hepatic elimination
of the dye following I/R has been analyzed mainly by
plasma clearance [4]. Very importantly was the study of
the hepatic elimination of the dye after a bolus injection
by compartmental spectrophotometric analysis both in the
perfusate by transhepatic sampling and in the bile. In fact,
this reﬂects the “eﬀective” vectorial hepatocellular transport.
Diﬀerential mechanisms can be suggested for the impaired
biliary excretion of organic anions following I/R. Previously,
a positive correlation between biliary dye excretion, viability
of the graft, and hepatic ATP content has been found in
cholestaticliverdisease,andreducedbiliarydyeexcretionhas
beenattributedtothelackofATP[17].ATPcontentdoesnot
seem to be the main limiting factor for the hepatocellular
transport following I/R. An impairment of the intracellular
transport or a decreased transport rate across the canalicular
membrane might play a major role as contributing factor.
The step across the canalicular membrane generally repre-
sents the rate-limiting one in the hepatocellular transport
[18]. In the canine liver transplantation model, the ﬂow
in the portal vein was continuous, because roller pump,
oxygenator, and heat exchanger in the perfusion line were
connected in series with the roller pump upstream. The
oxygen content of the saline reperfusion solution was 2% in
volume (10% of arterial hepatic blood and about 15% of the
portal venous blood). The pO2 values were almost ﬁve times
higher than in blood. Thus, one can expect to have reactive-
oxygen-species- (ROS-) linked damage at the beginning of
the reperfusion after 8 or 10h of ischemia. However, the
excellent reperfusion results of the control group and data
of the 2h ischemia group indicate that this is not a general
problem,butmaybeanischemia-time-linkedproblem.High
O2 partial pressure in the liver stimulates ROS formation
after extensive long ischemia times, and this may be one of
the most important limiting factorsof the ischemia tolerance
[22]. Electron microscopy studies in hepatocytes revealed
microﬁlaments, which are distributed along the plasma
membrane and in the region of the bile canaliculus. As indi-
cated above, cytoskeleton ﬁlaments are also essential for the
maintenance of cell shape, bile canalicular architecture, and
integrity of the cellular tight junctions. The microﬁlaments
network surrounding the canalicular pole and extending
into the canalicular microvilli is damaged during cholestasis.
Reperfusion, but not ischemia, has been considered faulty,
inducing an alteration of F-actin microﬁlaments, suggesting
an impairment of the canalicular contraction, an increase of
the tight junction permeability, and a probable relocalization
of canalicular enzymes and transporters. Bile canalicular size
change as detected in our study may be coincident with
the reorganization of the pericanalicular ﬁlaments and the
colocalizationofactinandmyosin.Infact,contractioninthis
study has been associated with shortening and/or twisting of
bile canaliculi [5].
7. Summary
Liver transplantation is an established therapy for both acute
and chronic liver failure. However, graft dysfunction remains
ap r o b l e ma ﬀecting up to one-third of the recipients, despite
good to excellent long-term outcome. The organ dysfunction
is considered multifactorial, but I/R injury is probably the
most important contributing factor. The detailed steps of
the pathogenesis of I/R injury continue to be a topic of
vivid debate. I/R injury is a major cause of liver graft
dysfunction resulting in ATP decrease, intracellular acidosis,
and cell swelling of the hepatocytes. This feature is also
linked to bile duct loss or ductopenia, cholestasis, and biliary
ductular proliferations in the liver biopsy. However, the
plasmatic levels of biliary markers increase usually only 5–
7 days after transplantation prompting on-going research
to address new markers of early liver damage. This could
also be a stimulus to support more grant approvals for liver
posttransplantation studies. Cholestasis is associated with
high morbidity and mortality in patients undergoing liver
transplantation, but the steps reaching this state are still
deemed elusive. We reviewed the canine LT model as an I/R
injury model and reviewed the intermediate ﬁlaments of the
cytoskeleton that are probably the determinants in changing
the phenotype of hepatocytes to cholangiocytes. In fact, this
phenotypic switch of the liver cells, which is also sometimes
called pseudo- or neoacinar transformation in diseases with
cholestasis [30], seems to occur at a stage earlier than frank
cholestasis. We emphasized that I/R injury through this
peculiar phenotypic switch of the hepatocytes may be a
milestone to investigate the pathways contributing to the
poor outcome of the liver graft. Reperfusion injury following
ischemia aﬀects graft function in liver transplantation by
inductionofphenotypicalchangesinhepatocellularkeratins.
Keratin phenotype of hepatocytes leads to hepatocellular
damage that is intimately connected to several intracellular
processes, which are under intense investigation in our
laboratory, and the appropriate choice of an animal model
is crucial in forwarding research in very complex areas
requiring not only human, but also comparative (veterinary)
pathology knowledge.Journal of Biomedicine and Biotechnology 5
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